Sapir-Koren R, Livshits G, Landsman T, Kobyliansky E
Research Unit-Human Population Biology, Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel Aviv-University, Ramat Aviv, Israel.
Anthropol Anz. 2001;59(4):343-53.
In order to identify genetic effects of allelic variation on bone mineral density (BMD), association studies have been performed recently. Examining the relation between PvuII and XbaI restriction fragment length polymorphism (RFLPs) at the estrogen receptor (ER alpha) gene and BMD, in women or men, have yielded conflicting results. We analyzed the association between this polymorphism and BMD Z score values of cancellous bone at the 3rd finger in 344 members of nuclear families of European population, Chuvasha, living in Russia. The population sample included 183 males, aged 18-84, and 161 females, aged 23-79. The analysis has been performed separately for both sexes and for both generations (parents and offspring). We used a novel direct haplotyping method, which determines simultaneously each of the PvuII and XbaI RFLPs and their relation to each other. The haplotypes were represented as the combination of both polymorphic sites on the same chromosome, by using P/p and X/x for PvuII and XbaI restriction sites, respectively. The subjects were classified into 3 groups of genotypes: A = PXPX (homozygote for the PX haplotype); B = PXPx, PXpx (the heterozygotes for the PX haplotype); C = PxPx, Pxpx, pxpx (genotypes that are lacking the PX haplotype). The PXPX genotype (A) was associated with higher BMD Z score values in comparison to the genotypes that are lacking the PX haplotype (C), in total males [0.618 vs. -0.133 (p = 0.004)] and for the "sons" generation [0.724 vs. -0.198 (p = 0.02)]. Similar tendency was observed for the "fathers" generation (0.539 vs. -0.085), though the difference did not approach statistical significance (p = 0.087). These findings were not found in the female samples, nor in the "mothers" or "daughters" generations. The question if there are differences in the mode of action of estrogen through its receptor on bone mass, between the genders or between the males' generations, have to be further investigated.
为了确定等位基因变异对骨矿物质密度(BMD)的遗传效应,最近进行了关联研究。在男性或女性中,研究雌激素受体(ERα)基因处的PvuII和XbaI限制性片段长度多态性(RFLP)与BMD之间的关系,结果相互矛盾。我们分析了居住在俄罗斯的楚瓦什欧洲人群核心家庭的344名成员中,这种多态性与第三指松质骨BMD Z评分值之间的关联。人群样本包括183名年龄在18 - 84岁的男性和161名年龄在23 - 79岁的女性。分析分别针对男女两性以及两代人(父母和后代)进行。我们使用了一种新颖的直接单倍型分型方法,该方法可同时确定每个PvuII和XbaI RFLP及其相互关系。单倍型通过使用P/p和X/x分别表示PvuII和XbaI限制性位点,以同一染色体上两个多态性位点的组合形式呈现。受试者被分为3组基因型:A = PXPX(PX单倍型纯合子);B = PXPx、PXpx(PX单倍型杂合子);C = PxPx、Pxpx、pxpx(缺乏PX单倍型的基因型)。与缺乏PX单倍型的基因型(C)相比,PXPX基因型(A)在所有男性中[0.618对 - 0.133(p = (0.004)]以及在“儿子”一代中[0.724对 - 0.198(p = 0.02)]与更高的BMD Z评分值相关。在“父亲”一代中也观察到类似趋势(0.539对 - 0.085),尽管差异未达到统计学显著性(p = 0.087)。在女性样本以及“母亲”或“女儿”一代中未发现这些结果。雌激素通过其受体对骨量的作用方式在性别之间或男性各代之间是否存在差异的问题,有待进一步研究。